Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Access to the MAGNETISMM-5 study page is replaced by a 403 Forbidden error, displaying the error content instead of the study record. As a result, users cannot view the trial details, eligibility criteria, locations, or contact information.
    Difference
    20%
    Check dated 2026-09-22T23:47:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new 'Find contact information' link/label was added and the revision tag updated to v3.7.0, while the previous 'Find Contact Information' label and Revision: v3.6.6 were removed.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Adds the disease term 'Multiple myeloma' to the page's content taxonomy. Introduces a 'related topics' section with 'MedlinePlus Genetics' as a resource link.
    Difference
    0.0%
    Check dated 2026-09-08T22:28:44.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page's revision identifier changed from v3.6.5 to v3.6.6, signaling a new release of the page. This update likely reflects minor fixes or improvements rather than changes to the study content or its functionality.
    Difference
    0.0%
    Check dated 2026-09-01T20:04:59.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Enrollment status on the study page has shifted to Terminated, indicating no further enrollment. The update also adds NIH grant/contract information and new date entries while removing the Recruiting indicator and the disease term Multiple myeloma from the visible content.
    Difference
    0.2%
    Check dated 2026-08-25T19:59:41.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.